dc.contributor.author
Mallock, Nadja
dc.contributor.author
Rabenstein, Andrea
dc.contributor.author
Laux, Peter
dc.contributor.author
Rüther, Tobias
dc.contributor.author
Hutzler, Christoph
dc.contributor.author
Parr, Maria Kristina
dc.contributor.author
Luch, Andreas
dc.date.accessioned
2021-11-09T08:32:41Z
dc.date.available
2021-11-09T08:32:41Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/32616
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-32340
dc.description.abstract
New nicotine delivery products are gaining market share. For evaluation of their characteristics, toxicokinetic investigations are in current research focus. For reliable determination of blood plasma levels of nicotine and its main metabolites cotinine and trans-3′-hydroxycotinine, a quantitation method based on LC-ESI-MS/MS was developed and validated. Addition of isotope labeled internal standards prior to rapid sample preparation using protein precipitation with methanol was chosen for sample preparation. Different stationary phases were tested and phenyl-hexyl separation was found to be superior to HILIC, C18, and C8 stationary phases. Ion suppression effects caused by hydrophilic early eluting matrix were eliminated by the adjustment of an adequate retention utilizing a phenyl-hexyl separation stationary phase. Exchange of acetonitrile as organic mobile phase by methanol and elevation of pH value of aqueous mobile phase containing 5 mM NH4Ac to 4.50 improved the chromatographic resolution. The limits of quantitation for nicotine, cotinine, and hydroxycotinine were 0.15, 0.30, and 0.40 ng/mL, respectively. Linearity was proven by matrix matched calibration for the whole working range from 0.50 ng/mL to 35.0 ng/mL for nicotine and from 6.00 to 420 ng/mL for cotinine and hydroxycotinine (Mandel’s fitting test with R2 > 0.995). Quality control samples at four different levels (0.50, 1.50, 17.5, 28.0 ng/mL for nicotine and 6.00, 18.0, 210, 336 ng/mL for cotinine and hydroxycotinine) in plasma were analyzed six times on three days. Mean accuracies ranged from 87.7% to 105.8% for nicotine, from 90.3% to 102.9% for cotinine, and from 99.9% to 109.9% for hydroxycotinine. Intra- and inter-day precisions (RSD %) were below 15% for all analytes (<20% for LLOQ). As proof of concept, the method was successfully applied to a real plasma sample from a cigarette smoking volunteer.
en
dc.format.extent
13 Seiten
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Hydroxycotinine
en
dc.subject
Protein precipitation
en
dc.subject
Phenyl-hexyl column
en
dc.subject.ddc
500 Naturwissenschaften und Mathematik::540 Chemie::540 Chemie und zugeordnete Wissenschaften
dc.title
Rapid, sensitive, and reliable quantitation of nicotine and its main metabolites cotinine and trans-3′-hydroxycotinine by LC-MS/MS: Method development and validation for human plasma
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
122736
dcterms.bibliographicCitation.doi
10.1016/j.jchromb.2021.122736
dcterms.bibliographicCitation.journaltitle
Journal of Chromatography B
dcterms.bibliographicCitation.volume
1179
dcterms.bibliographicCitation.url
https://doi.org/10.1016/j.jchromb.2021.122736
refubium.affiliation
Biologie, Chemie, Pharmazie
refubium.affiliation.other
Institut für Pharmazie
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.isPartOf.eissn
1873-376X
refubium.resourceType.provider
WoS-Alert